Phosphorylation of tyrosine residues in the kinase domain and juxtamembrane region regulates the biological and catalytic activities of eph receptors

被引:161
作者
Binns, KL
Taylor, PP
Sicheri, F
Pawson, T
Holland, SJ
机构
[1] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada
[2] Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1A8, Canada
关键词
D O I
10.1128/MCB.20.13.4791-4805.2000
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Members of the Eph family of receptor tyrosine kinases exhibit a striking degree of amino acid homology, particularly notable in the kinase and membrane-proximal regions. A mutagenesis approach was taken to address the functions of specific conserved tyrosine residues within these catalytic and juxtamembrane domains. Ligand stimulation of wild-type EphB2 in neuronal NG108-15 cells resulted in an upregulation of catalytic activity and an increase in cellular tyrosine phosphorylation, accompanied by a retraction of neuritic processes. Tyrosine-to-phenylalanine substitutions within the conserved juxtamembrane motif abolished these responses. The mechanistic basis for these observations was examined using the highly related EphA4 receptor in a continuous coupled kinase assay. Tandem mass spectrometry experiments confirmed autophosphorylation of the two juxtamembrane tyrosine residues and also identified a tyrosine within the kinase domain activation segment as a phosphorylation site. Kinetic analysis revealed a decreased affinity for peptide substrate upon substitution of activation segment or juxtamembrane tyrosines. Together, our data suggest that the catalytic and therefore biological activities of Eph receptors are controlled by a two-component inhibitory mechanism, which is released by phosphorylation of the juxtamembrane and activation segment tyrosine residues.
引用
收藏
页码:4791 / 4805
页数:15
相关论文
共 54 条
[1]   CHARACTERIZATION OF PP60(C-SRC) TYROSINE KINASE-ACTIVITIES USING A CONTINUOUS ASSAY - AUTOACTIVATION OF THE ENZYME IS AN INTERMOLECULAR AUTOPHOSPHORYLATION PROCESS [J].
BARKER, SC ;
KASSEL, DB ;
WEIGL, D ;
HUANG, XY ;
LUTHER, MA ;
KNIGHT, WB .
BIOCHEMISTRY, 1995, 34 (45) :14843-14851
[2]   Full activation of the platelet-derived growth factor β-receptor kinase involves multiple events [J].
Baxter, RM ;
Secrist, JP ;
Vaillancourt, RR ;
Kazlauskas, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (27) :17050-17055
[3]   SEVERAL RECEPTOR TYROSINE KINASE GENES OF THE EPH FAMILY ARE SEGMENTALLY EXPRESSED IN THE DEVELOPING HINDBRAIN [J].
BECKER, N ;
SEITANIDOU, T ;
MURPHY, P ;
MATTEI, MG ;
TOPILKO, P ;
NIETO, MA ;
WILKINSON, DG ;
CHARNAY, P ;
GILARDIHEBENSTREIT, P .
MECHANISMS OF DEVELOPMENT, 1994, 47 (01) :3-17
[4]   Cell-cell adhesion mediated by binding of membrane-anchored ligand LERK-2 to the EPH-related receptor human embryonal kinase 2 promotes tyrosine kinase activity [J].
Bohme, B ;
Vandenbos, T ;
Cerretti, DP ;
Park, LS ;
Holtrich, U ;
RubsamenWaigmann, H ;
Strebhardt, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (40) :24747-24752
[5]   Tyrosine phosphorylation of transmembrane ligands for Eph receptors [J].
Bruckner, K ;
Pasquale, EB ;
Klein, R .
SCIENCE, 1997, 275 (5306) :1640-1643
[6]   Partial activation of the insulin receptor kinase domain by juxtamembrane autophosphorylation [J].
Cann, AD ;
Bishop, SM ;
Ablooglu, AJ ;
Kohanski, RA .
BIOCHEMISTRY, 1998, 37 (32) :11289-11300
[7]   LIGANDS FOR EPH-RELATED TYROSINE KINASE RECEPTORS ARE DEVELOPMENTALLY-REGULATED IN THE CNS [J].
CARPENTER, MK ;
SHILLING, H ;
VANDENBOS, T ;
BECKMANN, MP ;
CERRETTI, DP ;
KOTT, JN ;
WESTRUM, LE ;
DAVISON, BL ;
FLETCHER, FA .
JOURNAL OF NEUROSCIENCE RESEARCH, 1995, 42 (02) :199-206
[8]   p62(dok): A constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells [J].
Carpino, N ;
Wisniewski, D ;
Strife, A ;
Marshak, D ;
Kobayashi, R ;
Stillman, B ;
Clarkson, B .
CELL, 1997, 88 (02) :197-204
[9]   Phosphorylation at Tyr-838 in the kinase domain of EphA8 modulates Fyn binding to the Tyr-615 site by enhancing tyrosine kinase activity [J].
Choi, S ;
Park, S .
ONCOGENE, 1999, 18 (39) :5413-5422
[10]  
COBB MH, 1989, J BIOL CHEM, V264, P18701